What is CAR T-Cell Therapy?

Chimeric Antigen Receptor T-cell (CAR T-cell) therapy is an advanced and groundbreaking treatment that is transforming the way we treat certain types of blood cancers. CAR T-cell therapy in India, especially in metro cities like Delhi NCR, is gaining momentum due to improved accessibility and medical advancements. Unlike traditional therapies such as chemotherapy or radiation, which attack both healthy and cancerous cells, CAR T-cell therapy focuses on using the body's own immune system to selectively target and destroy cancer cells. This approach is especially effective in treating cancers that are resistant to conventional treatments. CAR T therapy in Delhi NCR is now being offered at leading cancer centers like Fortis, giving patients new hope.

The Process of CAR T-Cell Therapy

• T-Cell Collection: The first step involves collecting T-cells from the patient’s blood through a process called apheresis. These immune cells are responsible for recognizing and responding to threats like infections and cancer.
• Genetic Modification: Once the T-cells are collected, they are sent to a laboratory where they are genetically modified. This involves inserting a gene that encodes a chimeric antigen receptor (CAR), which allows the T-cells to recognize a specific protein present on the surface of cancer cells.
• Expansion of T-Cells: After the modification, these CAR T-cells are multiplied in large numbers. This process can take several weeks, during which the T-cells are rapidly expanded in the lab.
• Infusion Back into the Patient: Once enough CAR T-cells have been grown, they are infused back into the patient’s bloodstream. These engineered T-cells now have the ability to identify and attack cancer cells with the targeted antigen, effectively eliminating them from the body.
• Targeting Cancer Cells: The CAR T-cells recognize the antigen on cancer cells and bind to them. This binding triggers a series of actions that lead to the destruction of the cancerous cells, either by direct killing or by recruiting other immune system components.

Why is CAR T-Cell Therapy Important?

The unique and innovative nature of CAR T-cell therapy offers several advantages over traditional cancer treatments, especially in cases where other treatments have failed. With increasing adoption of CAR T-cell therapy in Delhi NCR, patients can now access precision medicine within India itself.

• Precision Treatment: Unlike traditional cancer therapies, CAR T-cell therapy in India is highly specific, minimizing damage to healthy tissues.
• Potential for Long-Term Remission: Some patients experience complete and durable responses, with no signs of cancer for years.
• Personalized Treatment: CAR T-cell therapy is tailored to each patient using their own cells, which are now being processed efficiently in Delhi NCR cancer centers.

Indications: Which Types of Cancer Can Be Treated with CAR T-Cell Therapy?

Currently, CAR T-cell therapy is used to treat blood cancers like:

• B-cell Acute Lymphoblastic Leukemia (ALL)
• Diffuse Large B-cell Lymphoma (DLBCL)
• Follicular Lymphoma
• Multiple Myeloma
• Mantle Cell Lymphoma

Patients in Delhi NCR now have access to these treatments without the need to travel abroad, thanks to growing infrastructure and indigenous options.

How Effective is CAR T-Cell Therapy?

Clinical data supports high remission rates for CAR T-cell therapy. In India, especially in Delhi NCR, oncologists report improved outcomes in relapsed or refractory leukemia and lymphoma cases.

• In B-cell ALL, remission rates reach up to 80%.
• In DLBCL, about 40–50% of patients achieve complete response.

Such data makes CAR T-cell therapy in Delhi and CAR T treatment in India a promising cancer solution.

Risks and Side Effects of CAR T-Cell Therapy

Side effects, though manageable, can include:

• Cytokine Release Syndrome (CRS)
• Neurotoxicity
• Infections

Delhi-based hospitals like Fortis are equipped to handle these with advanced ICU setups and expert immunologists.

CAR T-Cell Therapy at Fortis Healthcare Delhi NCR

Fortis Healthcare offers cutting-edge CAR T-cell therapy in Gurgaon and Delhi NCR. Our multidisciplinary teams design personalized CAR T therapy plans supported by:

• State-of-the-art Technology
• Experienced Oncologists in Delhi NCR
• Comprehensive Cancer Care Units in Gurgaon

Patients searching for CAR T-cell therapy hospitals in Delhi NCR will find Fortis among the top-rated destinations.

CAR T-Cell Therapy in India: Accessibility and Cost

Thanks to innovations like NexCAR19, CAR T-cell therapy cost in India has become more accessible. Patients can now receive treatment in Delhi NCR, including Gurgaon, at a fraction of the international cost.

• CAR T-cell therapy in Delhi starts from around INR 30–40 lakhs depending on complexity.
• Indigenous CAR T options in India further reduce cost.

Conclusion: The Future of Cancer Treatment in Delhi NCR

CAR T-cell therapy in India is redefining cancer care. With advanced setups in Delhi NCR and growing success rates, this therapy offers new hope. If you or a loved one is exploring CAR T-cell therapy in Gurgaon or Delhi, Fortis Healthcare is your trusted partner.

Contact us today to explore CAR T-cell therapy cost in Delhi NCR, success rates, and personalized treatment options available near you.